Savannah Plastic Surgery Partners With Meridian Clinical Research, Creates New Clinical Trial Opportunities in Savannah
Meridian Clinical Research and Savannah Plastic Surgery are partnering to conduct clinical trials in Savannah, Ga. Dr. Luke Curtsinger and Dr. Matthew McLeod at Savannah Plastic Surgery will serve as principal investigators and lead the conduct of research studies for novel surgical approaches, pharmaceutical products, and medical devices. “Clinical research makes progress possible,” said Dr. Curtsinger. “Conducting trials will enable us to offer expanded care options to our patients today, and will drive the development of next generation treatment approaches.” This will be Meridian’s sixth site located in Savannah, and its first plastic and cosmetic research site in North America. … Read more
Savannah, Ga., April, 2, 2019 — Bounphone “Willow” Chanthavong, MPH, CCRC, director and research coordinator at Meridian’s neurology site in Savannah, Ga., was selected as a finalist for the PharmaTimes Clinical Researcher of the Year — The Americas 2019. The finals are the third stage of a competition that welcomes the highest scoring candidates from previous questionnaire and essay challenges. Willow and other Meridian staff will attend the finals day at the Sheraton Hotel in Boston, MA, on May 4. “Willow is more than deserving of the recognition,” said Taryn Collett, CRCC, east coast clinical operations manager at Meridian. “She’s … Read more
Ingrid Loma-Miller, MD, Selected to Serve on National Medical Advisory Committee for National Multiple Sclerosis Society
Norfolk, Va., March, 4, 2019 — Ingrid Loma-Miller, MD, has been selected to serve on the National Medical Advisory Committee for the National Multiple Sclerosis Society (NMSS). She is a principal investigator at Meridian Clinical Research, and is a physician at Neurology Specialists, a division of Neurology Consultants of Tidewater, PLLC in Norfolk, Va. Dr. Loma-Miller specializes in the diagnosis and treatment of patients with multiple sclerosis. As a member of the National Medical Advisory Committee, she will advise NMSS efforts to advance knowledge about multiple sclerosis care. “I’m honored to be selected,” said Dr. Loma-Miller. “I’ve focused on serving … Read more
Congratulations to Keith Vrbicky, MD! He was named Faith Regional’s 2018 Physician of the Year. Charles Harper, MD, a Meridian principal investigator, was also recognized for 10 years of service at Faith Regional. Read the full announcement here.
For 2018’s Good Deeds Day, employees at each Meridian site were given a cash stipend and a simple instruction: Go into your community and make a difference. We were blown away by the thoughtfulness with which each Meridian site chose to donate to the community, support local charities, or perform small acts of kindness. As we look forward to 2019 we want to thank the communities we serve. Here’s a recap of how we connected with our communities for Good Deeds Day 2018…
Positive Results Announced for Phase III Clinical Trial of Evofem Hormone-Free Birth Control Product; Meridian Site Involved
Evofem Biosciences, Inc. (NASDAQ: EVFM) (“Evofem” or the “Company”) today announced that its Phase 3 clinical trial of Amphora® for the prevention of pregnancy, AMPOWER, successfully met its primary endpoint. AMPOWER assessed the efficacy, safety and subject satisfaction with Amphora in approximately 1,400 healthy women aged 18-35 years at 112 centers in the U.S. The primary endpoint of the study was the pregnancy rate over seven cycles of use (one cycle = 21-35 days) as assessed by the Kaplan-Meier statistical method. Top-line data analysis demonstrates a cumulative pregnancy rate of 14.0% over seven cycles of use (95% CI 10.0, 18.0). … Read more
Michael Hemphill, MD, Receives Health Professional Impact Award from the National Multiple Sclerosis Society
Savannah, Ga., December 10, 2018 — Michael Hemphill, MD, has received the 2018 Health Professional Impact Award from the National Multiple Sclerosis Society (NMSS). He is a principal investigator at Meridian Clinical Research, and has been a physician at Savannah Neurology Specialists in Savannah, Ga., since 1981. The NMSS Health Professional Impact Award honors health professionals who have demonstrated their commitment to helping people with the challenges of multiple sclerosis by providing high-quality clinical care and serving in volunteer leadership positions. Dr. Hemphill received this award at an event in Atlanta, Ga. As a patient advocate for those afflicted with … Read more
Omaha, Neb., December 3, 2018 — Throughout the week of December 3-7, each Meridian Clinical Research location will celebrate a Good Deeds Day. This year’s activities will be held across all of Meridian’s 15 U.S. research sites, four remote offices, two call centers, and corporate office. For Good Deeds Day, employees at each Meridian site are given a cash stipend and a simple instruction: Go into your community and make a difference. Meridian employees decide on the best way to donate to the community, support local charities, or perform small acts of kindness. This tradition of spontaneous giving began more … Read more
Omaha, Neb., October 24, 2018 — Meridian Clinical Research will attend the 19th World Vaccine Congress (WVC) in Lisbon, Portugal from October 29 to 31. As a leading investigative site network for vaccines and infectious diseases, Meridian will have several representatives at the conference.
Meridian recently sponsored its first golf event with Muscular Dystrophy Association (MDA) at the Tiburon Golf Club in Omaha, NE. The event raised almost $20,000 to support future research and MDA Summer Camp. Thank you to everyone who participated — see you next year! The second MDA Golf Classic sponsored by Meridian is scheduled for September 18, 2019, at the Tiburon Golf Club.